Nuveen Asset Management, LLC Xencor Inc Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 837,082 shares of XNCR stock, worth $13.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

837,082

Previous 151,525 452.44%

Holding current value

$13.2 Million

Previous $3.05 Million 531.31%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$19.43 - $26.84 $13.3 Million - $18.4 Million	685,557 Added 452.44%	837,082 $19.2 Million
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $412,093 - $568,269	-26,248 Reduced 14.76%	151,525 $3.05 Million
Q2 2024 Aug 09, 2024	BUY	$18.21 - $24.5 $477,976 - $643,076	26,248 Added 17.32%	177,773 $3.37 Million
Q1 2024 May 13, 2024	SELL	$18.65 - $26.52 $275,814 - $392,204	-14,789 Reduced 8.89%	151,525 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $83,195 - $107,806	5,033 Added 3.12%	166,314 $3.53 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $1.06 Million - $1.34 Million	-52,730 Reduced 24.64%	161,281 $3.25 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $822,537 - $992,889	33,207 Added 18.37%	214,011 $5.34 Million
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $487,652 - $694,364	-18,792 Reduced 9.42%	180,804 $5.04 Million
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $688,864 - $857,537	-27,788 Reduced 12.22%	199,596 $5.2 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $422,208 - $556,313	17,149 Added 8.16%	227,384 $5.91 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $870,849 - $1.28 Million	44,116 Added 26.56%	210,235 $5.75 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $55,174 - $86,090	2,068 Added 1.26%	166,119 $4.71 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $481,413 - $621,105	-14,298 Reduced 8.02%	164,051 $5.55 Million
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $1.02 Million - $1.19 Million	-33,366 Reduced 15.76%	178,349 $6.17 Million
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $452,469 - $588,882	-13,180 Reduced 5.86%	211,715 $7.3 Million
Q1 2021 May 17, 2021	SELL	$40.81 - $53.88 $1.31 Million - $1.73 Million	-32,102 Reduced 12.49%	224,895 $9.68 Million
Q4 2020 Feb 16, 2021	SELL	$36.63 - $47.63 $1.54 Million - $2 Million	-41,933 Reduced 14.03%	256,997 $11.2 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $119,848 - $171,348	-3,983 Reduced 1.31%	298,930 $11.6 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $1.16 Million - $1.4 Million	41,920 Added 16.06%	302,913 $9.81 Million
Q1 2020 May 14, 2020	BUY	$20.69 - $37.79 $254,031 - $463,985	12,278 Added 4.94%	260,993 $7.8 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $146,130 - $184,860	-4,462 Reduced 1.76%	248,715 $8.55 Million
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $585,687 - $803,432	-17,364 Reduced 6.42%	253,177 $8.54 Million
Q2 2019 Aug 15, 2019	BUY	$29.6 - $40.93 $8.01 Million - $11.1 Million	270,541 New	270,541 $11.1 Million

Others Institutions Holding XNCR

# of Institutions

199

Shares Held

73.7M

Call Options Held

1.7K

Put Options Held

4.2K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $940M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Xencor Inc Transaction History